Lazard Asset Management LLC grew its holdings in shares of TriMas Corporation (NASDAQ:TRS – Free Report) by 43.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 157,984 shares of the industrial products company’s stock after purchasing an additional 47,885 shares during the quarter. Lazard Asset Management LLC’s holdings in TriMas were worth $5,678,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. Punch & Associates Investment Management Inc. acquired a new stake in TriMas during the first quarter worth about $8,795,000. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of TriMas in the 1st quarter valued at $7,015,000. Arrowstreet Capital Limited Partnership increased its stake in TriMas by 56.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 357,387 shares of the industrial products company’s stock worth $12,844,000 after purchasing an additional 128,811 shares during the period. Sei Investments Co. increased its stake in TriMas by 26.7% during the 1st quarter. Sei Investments Co. now owns 215,508 shares of the industrial products company’s stock worth $7,745,000 after buying an additional 45,444 shares during the period. Finally, State of Wyoming increased its position in shares of TriMas by 49.4% during the first quarter. State of Wyoming now owns 10,525 shares of the industrial products company’s stock worth $378,000 after acquiring an additional 3,481 shares during the period. 99.42% of the stock is currently owned by hedge funds and other institutional investors.
TriMas Stock Performance
Shares of TRS opened at $38.06 on Friday. The company has a current ratio of 4.85, a quick ratio of 4.50 and a debt-to-equity ratio of 0.27. TriMas Corporation has a 12-month low of $30.43 and a 12-month high of $45.42. The stock has a market cap of $1.36 billion, a P/E ratio of 1.58 and a beta of 0.59. The company has a 50-day moving average of $41.29 and a two-hundred day moving average of $38.38.
TriMas Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 13th. Stockholders of record on Thursday, August 6th will be paid a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Thursday, August 6th. TriMas’s dividend payout ratio (DPR) is currently 0.66%.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on TRS shares. Weiss Ratings upgraded shares of TriMas from a “buy (b-)” rating to a “buy (b)” rating in a research note on Tuesday, June 23rd. Zacks Research upgraded shares of TriMas from a “strong sell” rating to a “hold” rating in a research report on Tuesday, May 5th. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, TriMas currently has an average rating of “Moderate Buy” and a consensus target price of $41.50.
Check Out Our Latest Research Report on TriMas
Insider Buying and Selling
In related news, Director Herbert K. Parker sold 15,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $45.03, for a total transaction of $675,450.00. Following the transaction, the director directly owned 57,762 shares of the company’s stock, valued at approximately $2,601,022.86. The trade was a 20.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 17.50% of the stock is owned by company insiders.
Key Headlines Impacting TriMas
Here are the key news stories impacting TriMas this week:
- Positive Sentiment: TriMas reported second-quarter EPS of $0.52, exceeding the $0.49 analyst consensus. The company also raised its 2026 adjusted EPS outlook to $1.60-$1.70, supporting the view that cost controls, productivity initiatives, or a favorable business mix could bolster profitability. TriMas Q2 Earnings Top Estimates
- Positive Sentiment: Management maintained its 2026 sales-growth target of 3%-6%, indicating it continues to expect gradual improvement in demand despite recent revenue weakness. TriMas Raises 2026 Adjusted EPS Outlook
- Neutral Sentiment: Full-year revenue guidance of approximately $665.1 million-$684.5 million brackets the $679.3 million consensus estimate, while the EPS range of $1.60-$1.70 is broadly aligned with the $1.67 consensus. TriMas Earnings Report and Conference Call
- Negative Sentiment: Second-quarter revenue was $174.6 million, below the $178.4 million analyst estimate and down 36.5% from the prior-year period. EPS also declined from $0.61 a year earlier, signaling continued top-line and year-over-year profitability challenges. TriMas Q2 Earnings Snapshot
TriMas Company Profile
TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.
The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.
See Also
- Five stocks we like better than TriMas
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Corporation (NASDAQ:TRS – Free Report).
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.
